Winmill & Co. Inc Amgen Inc Transaction History

Winmill & Co. Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $3.59 Million - $4.11 Million	-18,050 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $207,700 - $254,877	1,050 Added 6.18%	18,050 $4.26 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $2.96 Million - $3.55 Million	17,000 New	17,000 $3.29 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Winmill & Co. Inc, based on Form 13F filings with the SEC.

Stay updated on Winmill & Co. Inc with notifications on news.